Key result
Cardiac myosin frequently undergoes power stroke reversal upon phosphate rebinding to maintain stable tension, whereas skeletal myosin rarely reverses and instead dissociates to save ATP.
Why the study?
Excessive phosphate concentrations impair contraction in cardiac and skeletal muscle, but the distinct structural dynamics and mechanisms cardiac and skeletal myosin use to counteract reduced contractile capacity remain unclear.
Cardiac and skeletal myosin exhibit distinct molecular dynamics upon Pi rebinding, suggesting that cardiac and skeletal muscle contraction disorders should be considered as distinct disease mechanisms.
Answers are grounded in this paper and cite their sources.
Requires distinct mechanistic models for cardiac versus skeletal muscle disorders; leaves open targeted therapeutic translation.
In recent years, significant advances have been made in various fields related to the study of myosin, including muscle fiber research, structural studies, and single-molecule measurements. These advances have provided detailed insights into the chemical and mechanical dynamics of myosin. As a result, numerous studies have been conducted on the temporal relationships between phosphate (Pi) release and force generation via myosin structural changes. These structural changes are a critical step in the myosin mechanochemical cycle. Two models have been proposed to explain this process. The first model proposes that force is generated by power stroke after Pi release, while the second model proposes that Pi is released after force generation by the power stroke. Furthermore, a comprehensive model has been proposed to elucidate phenomena predicted by both models. In this article, we explore the structural changes in myosin associated with Pi binding from a different perspective, based on our research, suggesting that the molecular structural dynamics associated with Pi rebinding, as well as its impact on force generation in molecular ensembles, exhibit distinct characteristics between cardiac myosin and skeletal myosin. It is widely acknowledged that an excessive increase in Pi concentration can adversely affect contraction function and contribute to the development of contraction-related diseases in both cardiac and skeletal muscle. In response to such adverse conditions, cardiac and skeletal myosin may employ different mechanisms to counteract the reduction in contractile capacity. Examining these potential mechanisms could facilitate the development of novel therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Motoshi Kaya (2025) conducted a review in Cardiac and skeletal muscle contraction. Phosphate (Pi) rebinding vs. Low or no phosphate was evaluated. Cardiac myosin frequently undergoes power stroke reversal upon phosphate rebinding to maintain stable tension, whereas skeletal myosin rarely reverses and instead dissociates to save ATP.
Synapse has enriched 10 related papers. Consider them for comparative context: